[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2006, 32(1) 48-50 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
�����
ϸ������
Ƥ������
���������������
������
��ɽ�
PubMed
Article by SHAO Li-ming
Article by ZHU Ke-jian

����غ�Ƥ����

������, ��ɽ�

�㽭��ѧҽѧԺ�������ݷ�ҽԺƤ����, ����310016

ժҪ��

������ǵ������Ƶ��׼�����³�Ա,������������ϸ������������,���Ҳ���ϸ����˿���ѺͰ��ʷ���ĵ��ڡ�����ؽ�����ڸ���Ƥ�������Բ���,�������������Ƥ������������ط��ӽṹ�����Ƶ����Ļ��ơ���ϸ�������е����á������������������Ƥ�����Ĺ�ϵ�Լ��������ơ�

�ؼ����� �����   ϸ������   Ƥ������  

Survivin and Skin Diseases

Department of Dermatology, Sir Run Run Shaw Hospital of Medical College of Zhejiang University, Hangzhou 310016, China

Department of Dermatology, Sir Run Run Shaw Hospital of Medical College of Zhejiang University, Hangzhou 310016, China

Abstract:

Survivin, a new member of the inhibitors of apoptosis protein (IAP) family, not only has the ability of inhibiting cell apoptosis, but also participates in the regulation of cell mitosis and cytokinesis. Survivin is selectively expressed in various kinds of benign and malignant skin lesions, but not in normal skin. This review focuses on the molecular structure of survivin, the mechanism of apoptosis inhibition, its role in cell division and the relationship of it with benign and malignant proliferative skin diseases. Survivin, as a novel therapeutic target of some skin diseases, has been postulated.

Keywords: Survivin   Apoptosis   Skin diseases  
�ո����� 2005-04-07 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����: ��ɽ�,E-mail:zhukejian@mail.hz.zj.cn
���߼��:

�ο����ף�
[1] Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma.Nat Med,1997,3:917-921.
[2] Verdecia MA,Huang H,Dutil E,et al.Structure of the human antiapoptotic protein survivin reveals a dimeric arrangement.Nat Struct Biol,2000,7:602-608.
[3] Conway EM,Pollefeyt S,Cornelissen J,et al.Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions.Blood,2000,95:1435-1442.
[4] Johnson ME,Howerth EW.Survivin:a bifunctional inhibitor of apoptosis protein.Vet Pathol,2004,41:599-607.
[5] Mahotka C,Liebmann J,Wenzel M,et al.Differential subcellular localization of functionally divergent survivin splice variants.Cell Death Differ,2002,9:1334-1342.
[6] O'Connor DS,Grossman D,Plescia J,et al.Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.Proc Natl Acad Sci U S A,2000,97:13103-13107.
[7] Marusawa H,Matsuzawa S,Welsh K,et al.HBXIP functions as a cofactor of survivin in apoptosis suppression.EMBO J,2003,22:2729-2740.
[8] Wang Z,Fukuda S,Pelus LM.Survivin regulates the p53 tumor suppressor gene family.Oncogene,2004,23:8146-8153.
[9] Yang D,Welm A,Bishop JM.Cell division and cell survival in the absence of survivin.Proc Natl Acad Sci U S A,2004,101:15100-15105.
[10] Grossman D,Kim PJ,Blanc-Brude OP,et al.Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.J Clin Invest,2001,108:991-999.
[11] Grossman D,McNiff JM,Li F,et al.Expression of the apoptosis inhibitor,survivin,in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.Lab Invest,1999,79:1121-1126.
[12] Allen SM,Florell SR,Hanks AN,et al.Survivin expression in mouse skin prevents papilloma regression and promotes chemicalinduced tumor progression.Cancer Res,2003,63:567-372.
[13] Bowen AR,Hanks AN,Murphy KJ,et al.Proliferation,apoptosis,and survivin expression in keratinocytic neoplasms and hyperplasias.Am J Dermatopathol,2004,26:177-181.
[14] Park HR,Min SK,Cho HD,et al.Expression profiles of p63,p53,survivin,and hTERT in skin tumors.J Cutan Pathol,2004,31:544-549.
[15] Lo Muzio L,Staibano S,Pannone G,et al.Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.Exp Mol Pathol,2001,70:249-254.
[16] Grossman D,Altieri DC.Drug resistance in melanoma:mechanisms,apoptosis,and new potential therapeutic targets.Cancer Metastasis Rev,2001,20:3-1 l.
[17] Grossman D,Kim PJ,Schechner JS,et al.Inhibition of melanoma tumor growth in vivo by survivin targeting.Proc Natl Acad Sci U S A,2001,98:635-640.
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־